BS print

Embed Size (px)

Citation preview

  • 8/11/2019 BS print

    1/28

  • 8/11/2019 BS print

    2/28

  • 8/11/2019 BS print

    3/28

    Intra Cranial Pressure

  • 8/11/2019 BS print

    4/28

    Traumatic Brain Injury

  • 8/11/2019 BS print

    5/28

    Traumatic Brain Injury

  • 8/11/2019 BS print

    6/28

    Brain edema

  • 8/11/2019 BS print

    7/28

    I

  • 8/11/2019 BS print

    8/28

  • 8/11/2019 BS print

    9/28

    Hypertonic Saline VS Manitol

    VS

  • 8/11/2019 BS print

    10/28

    Hypertonic Saline

  • 8/11/2019 BS print

    11/28

    Journal Reading

  • 8/11/2019 BS print

    12/28

    Introduction

    Traumatic brain injury (TBI) is the leading

    cause of morbidity and mortality in young

    adults

    When treating TBI, optimal intracranial

    pressure (ICP) control (< 20mmHg) and an

    adequate cerebral perfusion pressure of 50 to

    70 mmHg are goals associated with lowermortality

  • 8/11/2019 BS print

    13/28

    While mannitol has long been a mainstay of

    ICP management, the use of hypertonic saline

    (HTS) has more recently gained increasing

    support.

  • 8/11/2019 BS print

    14/28

    Material and methods

    Study design : Retrospective

    Sample : All consecutive patients admitted to

    the Regional Medical Center at Memphis for

    TBI between January 2006 and March 2011

    who received at least one dose of HTS

  • 8/11/2019 BS print

    15/28

    Patient Treatment

    Patient with severe TBIICP Monitor

    ICP and CPP recorded hourly

    Monitoring the serum sodium concentrationevery 6 hours

    Using HTS to raise it above 145 mEq/l

    Most patients received 150 ml of 3% HTSintravenously over 2 hours

  • 8/11/2019 BS print

    16/28

    Outcome

    Primary outcome : the relationship between

    serum sodium and the corresponding

    maximum ICP

    Secondary outcome : the relationship

    between the serum sodium and the number

    of therapeutic interventions for increased ICP

    management, and the acute effect of HTSboluses on ICP.

  • 8/11/2019 BS print

    17/28

    Methods

    Each serum sodium value was matched with

    the highest corresponding ICP

    The change in serum sodium was matched

    with the change in ICP

    To account for interpatient variability, serum

    sodium and the corresponding maximum ICP

    for each individual patient were also

    determined.

  • 8/11/2019 BS print

    18/28

    Methods for secondary outcome

    patients were divided into three groups basedon their mean daily serum sodium: < 145mEq/l, 145 to 155 mEq/l, and > 155 mEq/l.

    The following treatments were included as anintervention:

    HTS infusion

    Mannitol infusion, sedation or analgesia given by

    continuous infusion, neuromuscular blocker (NMB) infusion, pentobarbital

    infusion, or acute hyperventilation

  • 8/11/2019 BS print

    19/28

    Statistical Analysis

    Continous variableT-test for normallydistributed variable, Wilcoxon test for non-normally distributed variables.

    Proportions were compared using the chi-squared test.

    Linear regression was used to evaluate therelationship between serum sodium levels and

    corresponding maximum ICP Multiple pairwise comparisons were made using

    Dunns method.

  • 8/11/2019 BS print

    20/28

    Result

    A total of 81 patients with TBI were enrolledinto the study

    Sixty-eight patients (84%) received 3% sodium

    chloride boluses only. The remaining patientsreceived a combination of 3% and 7.5% sodiumchloride boluses, and/or continuous infusions of3% sodium chloride.

    A total of 1,230 serum sodium values (sodiumrange, 118 to 174 mEq/l) and 7,483 ICP values(ICP range, 0 to 159 mmHg) were collected

  • 8/11/2019 BS print

    21/28

    Baseline demographic and clinical

    characteristic

  • 8/11/2019 BS print

    22/28

    Patients

    serum sodium concentrations and their corresponding

    maximum ICP

  • 8/11/2019 BS print

    23/28

    Correlation between serum sodium

    and ICP

  • 8/11/2019 BS print

    24/28

    HTS Bolus

  • 8/11/2019 BS print

    25/28

    Strengths and limitations

    Retrospectivelack of control group

    it was not possible to find a control group

    that did not receive HTS

    The inability to relate the time of

    neurosurgical interventions is problematic due

    to the effect such procedures could have on

    ICP

    StrengthLarge sample

  • 8/11/2019 BS print

    26/28

    Conclussion

    Serum sodium concentrations did not

    correlate with ICP values. These results

    warrant further evaluation and possible

    reassessment of sodium goals for ICPmanagement in patients with TBI.

  • 8/11/2019 BS print

    27/28

    KEY message

    Serum sodium values do not correlate well with

    ICP in patients with TBI treated with HTS.

    Achieving serum sodium values between 145 and

    155 mEq/l may decrease the number of daily

    interventions

    required to manage elevated ICP.

    HTS boluses did not significantly decrease ICP

    overall.

  • 8/11/2019 BS print

    28/28